What does Cell Source, Inc. do?

Cell Source, Inc. is a public company in the Pharmaceutical Preparations industry, incorporated in NV. It is registered with the SEC under CIK 0001569340 and trades on OTC under the ticker CLCS.

Is Cell Source, Inc. profitable?

Cell Source, Inc. reported a net loss of $5.32M in FY2023. This figure is sourced from its SEC EDGAR 10-K annual report.

How many SEC filings has Cell Source, Inc. made?

Cell Source, Inc. has filed 137 documents with the SEC since 2013. These include annual reports (10-K), quarterly reports (10-Q), current event notices (8-K), and insider transaction disclosures (Form 4).

Cell Source, Inc.

CLCS OTC CIK: 0001569340 Pharmaceutical Preparations Inc. in NV

View on SEC.gov →

Overview All Filings Financials Insiders

Recent Filings

All 137 filings →

Form	Description	Date
15-12G	15-12G	Jul 16, 2025
8-K	8-K	Jun 27, 2025
NT 10-K	—	Mar 28, 2025
10-Q	—	Nov 14, 2024
10-Q	—	Aug 19, 2024
NT 10-Q	—	Aug 14, 2024
10-Q	—	Jul 29, 2024
10-K	—	Jun 24, 2024
8-K	—	Apr 9, 2024
NT 10-K	—	Apr 1, 2024

Insider Transactions

View all →

No insider transactions loaded yet.

About This Profile

This page aggregates all publicly available SEC EDGAR data for Cell Source, Inc.. Financial figures are sourced from XBRL-tagged 10-K annual reports. Insider transactions are sourced from Form 4 filings required within two business days of a transaction.

Key Financials

Net Income: ($5.32M) (FY2023)
Total Assets: $195.2K (FY2023)
Operating Income: ($4.33M)

Full financials →

Details

CIK: 0001569340
Ticker: CLCS
Exchange: OTC
Incorporated: NV
First Filing: 2013
Total Filings: 137